Holen Sie sich die Stockscreener-App
8.39
5.41%
-0.48
Handel nachbörslich:
8.39
Schlusskurs vom Vortag:
$8.87
Offen:
$8.83
24-Stunden-Volumen:
4.92M
Relative Volume:
0.71
Marktkapitalisierung:
$1.60B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.4541
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
-6.78%
1M Leistung:
-36.00%
6M Leistung:
-7.70%
1J Leistung:
-44.51%
1-Tages-Spanne:
$8.355
$8.83
1-Wochen-Bereich:
$8.355
$9.24
52-Wochen-Spanne:
$6.76
$15.68
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.39 | 1.60B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
236.43 | 38.38B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
75.30 | 13.03B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
61.31 | 11.50B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
101.67 | 8.81B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.74 | 7.88B | 640.44M | -743.28M | -206.93M | -11.29 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Health (TDOC): Among the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey
Unparalleled Research on Video-Based Telemedicine Platforms - openPR
BetterHelp Says Insurer Must Cover FTC Deal, Privacy Litigation - Bloomberg Law
Upcoming Opportunities in Pediatric Telehealth Solutions - openPR
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy? - Yahoo Finance
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth - MSN
Virtual Care Market Report | Industry Trends & Future Outlook - openPR
Teladoc Expands Specialty Care Access With Carrum Health Partnership - MSN
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner - Quantisnow
Teladoc's Game-Changing Partnership Solves Major Healthcare Integration Challenge for 93M Members - StockTitan
Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032:Teladoc Health, Amwell, Doctor - EIN News
Teladoc Doubles Down on Connected Care With New Partnerships - MSN
Teladoc Doubles Down On Connected Care With New Partnerships - Barchart
Cylinder joins Teladoc Health’s Connected Care Program to expand access to virtual digestive care - TradingView
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Teladoc partners with virtual fertility, digestive care companies - Modern Healthcare
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Teladoc Health Expands Connected Care Partnerships - GlobeNewswire
Teladoc Health Expands Connected Care Partnerships to Enhance Virtual Health Services Across Multiple Care Categories - Nasdaq
Teladoc Health Adds 4 Game-Changing Partners to Transform Virtual Healthcare Delivery - StockTitan
Proficio Capital Partners LLC Acquires New Stake in Teladoc Health, Inc. (NYSE:TDOC) - Defense World
Digital Therapeutics Market is expected to reach US$ 27.3 - openPR
Teladoc Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationTDOC - ACCESS Newswire
Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Principal Financial Group Inc. - Defense World
Teladoc Health (NYSE:TDOC) Shares Gap Down – Here’s What Happened - Defense World
Teladoc short seller attack on therapy unit highlights rise of AI - BenefitsPro
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan - Benzinga
Teladoc Health, Inc. to Host Earnings Call - ACCESS Newswire
Teladoc Health executive sells shares worth $32,733 - Investing.com
Teladoc stock jumps on GLP-1 deal with Eli Lilly - Yahoo Finance
Truist maintains Teladoc stock Hold rating, $10 target - Investing.com
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound - MSN
Teladoc partners with Eli Lilly, Burlington stock rises: Market Minute - Yahoo Finance
Truist Securities Reiterates Hold Rating on Teladoc (TDOC) - StreetInsider.com
Two telehealth firms turn to branded Zepbound as restrictions loom on copies - Reuters
Teladoc, LifeMD partner with Eli Lilly on GLP-1s - Modern Healthcare
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss - Benzinga India
Teladoc Health Provides Self-Pay Option for Eli Lilly's Obesity Drug -March 06, 2025 at 09:31 am EST - Marketscreener.com
Teladoc shares rise on partnership with LillyDirect on weight care program - Investing.com
Teladoc Health Adds GLP-1 Self-Pay Option To Comprehensive Weight Care -March 06, 2025 at 09:09 am EST - Marketscreener.com
Teladoc announces pharmacy integration agreement with Gifthealth - TipRanks
Teladoc shares rise on partnership with LillyDirect on weight care program By Investing.com - Investing.com Canada
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - TradingView
Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care - GlobeNewswire
TDOCTeladoc Health Inc Latest Stock News & Market Updates - StockTitan
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
The Future of Telemedicine: $488.89 Billion Market by 2033, - openPR
Teladoc's Latest Acquisition Comes With Nearly 1M Share Compensation Package - StockTitan
Teladoc Health Enhances Prism Platform for Better Virtual Care - MSN
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
2.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):